Anti-BCL2L15抗體,實(shí)驗(yàn)方法BCL2樣15促凋亡蛋白抗體產(chǎn)品經(jīng)無(wú)數(shù)次市場(chǎng)驗(yàn)證，若出現(xiàn)質(zhì)量問(wèn)題可無(wú)條件換貨或退貨,詳細(xì)信息：

產(chǎn)品詢價(jià) 或（成）客服

英文名稱 BCL2L15
抗體名稱 Anti-BCL2L15抗體,實(shí)驗(yàn)方法BCL2樣15促凋亡蛋白抗體
別    名 B2L15_HUMAN; Bcl-2-like protein 15; Bcl2-L-15; BCL2-like 15; Bcl2l15; Bfk; C1orf178; FLJ22588; pro-apoptotic Bcl-2 protein.   
研究領(lǐng)域 細(xì)胞生物  細(xì)胞凋亡  
抗體來(lái)源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 18kDa
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human BCL2L15 (95-135aa)
亞    型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

上海研盟生物其它優(yōu)勢(shì)產(chǎn)品：

13596R Anti-Ecat1抗體,胚胎干細(xì)胞相關(guān)轉(zhuǎn)錄因子1抗體
13634R Anti-EMR2抗體,CD312抗體
13719R Anti-EPB41L5抗體,紅細(xì)胞膜蛋白條帶EPB41L5抗體
13761R Anti-EID2抗體,EID2蛋白抗體
4889R Anti-EpCAM抗體,上皮細(xì)胞粘附分子抗體
7359R Anti-ERG3抗體,癌基因ERG3抗體
10605R Anti-Ear5抗體,嗜酸性粒細(xì)胞陽(yáng)離子型核糖核酸酶5抗體
14117R Anti-EOLA1/CXorf40A抗體,內(nèi)皮細(xì)胞高表達(dá)脂多糖相關(guān)因子1抗體
14175R Anti-phospho-ETS2(Thr72),磷酸化癌基因ETS2抗體
4314R Anti-EIF1AY抗體,真核翻譯起始因子1A抗體
10209R Anti-EphA2抗體,內(nèi)皮細(xì)胞受體蛋白*激酶抗體
10247R Anti-E2F1抗體,轉(zhuǎn)錄因子E2F-1抗體
10659R Anti-Ephrin-B2抗體,Ephrin-B2抗體
7371R Anti-Ephrin B2抗體,Ephrin B2蛋白抗體
14481R Anti-EAN57抗體,EAN57蛋白抗體
14482R Anti-EAP30抗體,EAP30蛋白抗體
14483R Anti-EAPP抗體,EAPP蛋白抗體
14484R Anti-EBF4抗體,早期B淋巴細(xì)胞因子4抗體
14494R Anti-EBNA 3C抗體,EB病毒核抗原-3C抗體

抗體原理 
（1）特異性結(jié)合抗原：抗體本身不能直接溶解或殺傷帶有特異抗原的靶細(xì)胞，通常需要補(bǔ)體或吞噬細(xì)胞等共同發(fā)揮效應(yīng)以清除病原微生物或?qū)е虏±頁(yè)p傷。然而，抗體可通過(guò)與病毒或毒素的特異性結(jié)合，直接發(fā)揮中和病毒的作用。 
（2）激活補(bǔ)體：IgM、IgG1、IgG2和IgG3可通過(guò)經(jīng)典途徑激活補(bǔ)體，凝聚的IgA、IgG4和IgE可通過(guò)替代途徑激活補(bǔ)體。 
（3）結(jié)合細(xì)胞：不同類別的免疫球蛋白，可結(jié)合不同種的細(xì)胞，參與免疫應(yīng)答。 
（4）可通過(guò)胎盤及粘膜：免疫球蛋白G（IgG）能通過(guò)胎盤進(jìn)入胎兒血流中，使胎兒形成自然被動(dòng)免疫。免疫球蛋白A（IgA）可通過(guò)消化道及呼吸道粘膜，是粘膜局部抗感染免疫的主要因素。 
（5）具有抗原性：抗體分子是一種蛋白質(zhì)，也具有刺激機(jī)體產(chǎn)生免疫應(yīng)答的性能。不同的免疫球蛋白分子，各具有不同的抗原性。 
（6）抗體對(duì)理化因子的抵抗力與一般球蛋白相同：不耐熱，60～70℃即被破壞。各種酶及能使蛋白質(zhì)凝固變性的物質(zhì)，均能破壞抗體的作用?？贵w可被中性鹽類沉淀。在生產(chǎn)上?？捎昧蛩徜@或硫酸鈉從免疫血清中沉淀出含有抗體的球蛋白，再經(jīng)透析法將其純化。
產(chǎn)品介紹 BCL2L15 is a 163 amino acid protein and novel member of the Bcl-2 family that contains both BH2 and BH3 regions, but not BH1, BH4 or a C-terminal hydrophobic membrane anchor. Like Bcl-GL, Bfk does not bind to any Bcl-2 family members, even though its BH3 motif can mediate association with prosurvival proteins. Bfk localizes to cytoplasm, but unlike Bcl-GL, Bfk does not associate with organelles. Existing as four alternatively spliced isoforms, the pro-apoptotic isoforms of Bfk may help to protect against the development of human gastrointestinal malignancy. Bfk is found at low levels in stomach, ovary, bone marrow and spleen, but Bfk is highly expressed in mammary gland during pregnancy, suggesting that Bfk may play a role in mammary development. Bfk appears to be a cytosolic protein whose gene maps to chromosome 1p13.2. Chromosome 1 is the largest human chromosome spanning about 260 million base pairs and making up 8% of the human genome.

運(yùn)輸方面：現(xiàn)貨供應(yīng)，一般為快遞運(yùn)輸，江浙滬隔天到，外地及偏遠(yuǎn)地方三至五天時(shí)間到貨。